Cameron Gray - 14 Jun 2022 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Reporting relationship: Director
Issuer ticker: CUE
Reported as of: 14 Jun 2022
Net transaction value: +$1.3
SEC form: 4
Accepted by SEC: 16 Jun 2022, 16:01:21 UTC
Prior SEC filing: 05 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Cameron Gray by Colin Sandercock attorney-in-fact

Key filing fact

Cameron Gray filed Form 4 for Cue Biopharma, Inc. (CUE) on 16 Jun 2022.

Key facts

This page summarizes Cameron Gray's Form 4 filing for Cue Biopharma, Inc. (CUE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2022, 16:01.

Change

Previous filing in this sequence was filed on 05 Jan 2022.
Current net transaction value: +$1.3.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CUE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $165,000
Shares: +61,111
Change %: +9%
Price: $2.70
Shares after: 738,611
Date: 14 Jun 2022
Ownership: Direct

CUE transaction

Common Stock

Tax liability

Transaction value: $164,998
Shares: -51,562
Change %: -7%
Price: $3.20
Shares after: 687,049
Date: 14 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CUE transaction Derivative

Warrants

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -61,111
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 61,111
Exercise price: $2.70

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 14, 2022, the reporting person exercised a warrant to purchase 61,111 shares of the Issuers common stock for $2.70 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding of 51,562 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 9,549 shares.